(VIANEWS) – Columbia Banking System (COLB), Neurocrine Biosciences (NBIX), Agree Realty Corporation (ADC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Columbia Banking System (COLB)
208.5% sales growth and 6.18% return on equity
Columbia Banking System, Inc. operates as the bank holding company for Columbia State Bank that provides a range of banking services to small and medium-sized businesses, professionals, and individuals in Washington, Oregon, and Idaho. It offers personal banking products and services, including non-interest and interest-bearing checking, savings, money market, and certificate of deposit accounts; home mortgages for purchases and refinances, home equity loans and lines of credit, and other personal loans; debit and credit cards; and digital banking services. The company also provides business banking products and services, such as checking, savings, interest-bearing money market, and certificate of deposit accounts; agricultural, asset-based, builder and other commercial real estate loans, as well as loans guaranteed by the small business administration; debit and credit cards; and professional banking, treasury management, merchant card, and international banking services. In addition, it offers wealth management solutions that include financial planning services, such as asset allocation, net worth analysis, estate planning and preservation, education funding, and wealth transfer; insurance solutions, which include long-term care, and life and disability insurance; individual retirement solutions comprising retirement planning, retirement income strategies, and traditional and roth individual retirement accounts; and business solutions, which comprise business retirement plans, key person insurance, business succession planning, and deferred compensation plans to individuals, families, and professional businesses. Further, the company provides fiduciary, investment, and administrative trust services, such as personal and special needs trusts, estate settlement services, and investment agency and charitable management services. As of December 31, 2020, it operated approximately 145 branches. The company was founded in 1993 and is headquartered in Tacoma, Washington.
Earnings Per Share
As for profitability, Columbia Banking System has a trailing twelve months EPS of $0.75.
PE Ratio
Columbia Banking System has a trailing twelve months price to earnings ratio of 28.79. Meaning, the purchaser of the share is investing $28.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.18%.
2. Neurocrine Biosciences (NBIX)
23.9% sales growth and 4.16% return on equity
Neurocrine Biosciences, Inc., a neuroscience-focused biopharmaceutical company, discovers, develops, and delivers various treatments for people with neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products also include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; NBI-827104 to treat rare pediatric epilepsy and other indications; and crinecerfont. The company's products in clinical development also comprise NBI-1065844 for the treatment of negative symptoms of schizophrenia; NBI-1065845 for the treatment of resistant depression; and NBI-1065846 for treating anhedonia in depression. It has license and collaboration agreements with Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL – Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; AbbVie Inc.; and Sentia Medical Sciences Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Neurocrine Biosciences has a trailing twelve months EPS of $0.63.
PE Ratio
Neurocrine Biosciences has a trailing twelve months price to earnings ratio of 154.29. Meaning, the purchaser of the share is investing $154.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.16%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 522.2% and 30.4%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 35.4%, now sitting on 1.6B for the twelve trailing months.
3. Agree Realty Corporation (ADC)
20.4% sales growth and 3.74% return on equity
Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of June 30, 2020, the Company owned and operated a portfolio of 936 properties, located in 46 states and containing approximately 18.4 million square feet of gross leasable area. The common stock of Agree Realty Corporation is listed on the New York Stock Exchange under the symbol "ADC".
Earnings Per Share
As for profitability, Agree Realty Corporation has a trailing twelve months EPS of $1.79.
PE Ratio
Agree Realty Corporation has a trailing twelve months price to earnings ratio of 37.39. Meaning, the purchaser of the share is investing $37.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.74%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 4.4% and a negative 6.5%, respectively.
Sales Growth
Agree Realty Corporation’s sales growth is 22.2% for the current quarter and 20.4% for the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jul 27, 2023, the estimated forward annual dividend rate is 2.92 and the estimated forward annual dividend yield is 4.28%.
Yearly Top and Bottom Value
Agree Realty Corporation’s stock is valued at $66.92 at 11:23 EST, way below its 52-week high of $80.44 and higher than its 52-week low of $63.34.
4. Rockwell Automation (ROK)
11.8% sales growth and 40.98% return on equity
Rockwell Automation, Inc. provides industrial automation and digital transformation solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company operates through three segments, Intelligent Devices, Software & Control, and Lifecycle Services. Its solutions include hardware and software products and services. The Intelligent Devices segment offers drives, motion, safety, sensing, industrial components, and configured-to-order products. The Software & Control segment provides control and visualization software and hardware, information software, and network and security infrastructure solutions. The Lifecycle Services segment provides consulting, professional services and solutions, and connected and maintenance services. The company sells its solutions primarily through independent distributors in relation with its direct sales force. It serves discrete end markets, including automotive, semiconductor, and warehousing and logistics, as well as general industries comprising printing and publishing, marine, glass, fiber and textiles, airports, and aerospace; hybrid end markets, such as food and beverage, life sciences, household and personal care, and tire, as well as eco industrial, including water/wastewater, waste management, mass transit, and renewable energy; and process end markets comprising oil and gas, mining, metals, chemicals, pulp and paper, and others. Rockwell Automation, Inc. was founded in 1903 and is headquartered in Milwaukee, Wisconsin.
Earnings Per Share
As for profitability, Rockwell Automation has a trailing twelve months EPS of $11.35.
PE Ratio
Rockwell Automation has a trailing twelve months price to earnings ratio of 29.18. Meaning, the purchaser of the share is investing $29.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.98%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 10, 2023, the estimated forward annual dividend rate is 4.72 and the estimated forward annual dividend yield is 1.37%.
Previous days news about Rockwell Automation(ROK)
- What's in store for rockwell automation (rok) in Q3 earnings?. According to Zacks on Wednesday, 26 July, "In the past few quarters, Rockwell Automation has witnessed an improvement in order levels. ", "Our proven model predicts an earnings beat for Rockwell Automation this time around. "
5. Middlesex Water Company (MSEX)
8.4% sales growth and 9.22% return on equity
Middlesex Water Company owns and operates regulated water utility and wastewater systems. It operates in two segments, Regulated and Non-Regulated. The Regulated segment collects, treats, and distributes water on a retail and wholesale basis to residential, commercial, industrial, and fire protection customers in parts of New Jersey, Delaware, and Pennsylvania. This segment also includes regulated wastewater systems in New Jersey and Delaware. The Non-Regulated segment provides non-regulated contract services for the operation and maintenance of municipal and private water and wastewater systems in New Jersey and Delaware. The company was incorporated in 1896 and is headquartered in Iselin, New Jersey.
Earnings Per Share
As for profitability, Middlesex Water Company has a trailing twelve months EPS of $2.06.
PE Ratio
Middlesex Water Company has a trailing twelve months price to earnings ratio of 39.21. Meaning, the purchaser of the share is investing $39.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.22%.
Yearly Top and Bottom Value
Middlesex Water Company’s stock is valued at $80.78 at 11:23 EST, way below its 52-week high of $96.19 and way above its 52-week low of $66.51.
6. National Health Investors (NHI)
7.4% sales growth and 6.58% return on equity
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Earnings Per Share
As for profitability, National Health Investors has a trailing twelve months EPS of $2.09.
PE Ratio
National Health Investors has a trailing twelve months price to earnings ratio of 25.73. Meaning, the purchaser of the share is investing $25.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.58%.
Sales Growth
National Health Investors’s sales growth is 32.8% for the current quarter and 7.4% for the next.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 28, 2023, the estimated forward annual dividend rate is 3.6 and the estimated forward annual dividend yield is 6.72%.
Yearly Top and Bottom Value
National Health Investors’s stock is valued at $53.78 at 11:23 EST, way below its 52-week high of $67.16 and way higher than its 52-week low of $47.54.
7. BorgWarner (BWA)
5.8% sales growth and 13.74% return on equity
BorgWarner Inc. provides solutions for combustion, hybrid, and electric vehicles worldwide. The company's Engine segment offers turbocharger and turbocharger actuators; eBoosters; and timing systems products, including timing chains, variable cam timing, crankshaft and camshaft sprockets, tensioners, guides and snubbers, front-wheel drive transmission chains, four-wheel drive chains, and hybrid power transmission chains. It also provides emissions systems, such as electric air pumps and exhaust gas recirculation (EGR) modules, EGR coolers and valves, glow plugs, and instant starting systems; thermal systems products comprising viscous fan drives, polymer fans, coolant pumps, cabin heaters, battery heaters, and battery charging; and gasoline ignition technologies. The company's Drivetrain segment offers friction and mechanical products that include dual and friction clutch modules, friction and separator plates, transmission bands, torque converter and one-way clutches, and torsional vibration dampers. It also provides electro-hydraulic solenoids, transmission solenoid modules, and dual clutch control modules; rear-wheel drive/all-wheel drive (AWD) transfer case systems, front wheel drive-AWD coupling systems, and cross-axle coupling systems; starters, alternators, and hybrid electric motors; and motor controllers, battery chargers, and uninterrupted power source systems. The company sells its products to original equipment manufacturers of light vehicles, which comprise passenger cars, sport-utility vehicles, vans, and light trucks; commercial vehicles, including medium-duty and heavy-duty trucks, and buses; and off-highway vehicles, such as agricultural and construction machinery, and marine applications, as well as to tier one vehicle systems suppliers and the aftermarket for light, commercial, and off-highway vehicles. The company was formerly known as Borg-Warner Automotive, Inc. BorgWarner Inc. was founded in 1987 and is headquartered in Auburn Hills, Michigan.
Earnings Per Share
As for profitability, BorgWarner has a trailing twelve months EPS of $4.08.
PE Ratio
BorgWarner has a trailing twelve months price to earnings ratio of 10.98. Meaning, the purchaser of the share is investing $10.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.74%.
Yearly Top and Bottom Value
BorgWarner’s stock is valued at $44.81 at 11:23 EST, under its 52-week high of $45.53 and way above its 52-week low of $27.41.
Previous days news about BorgWarner(BWA)
- Borgwarner (bwa) stock sinks as market gains: what you should know. According to Zacks on Tuesday, 25 July, "Investors will be hoping for strength from BorgWarner as it approaches its next earnings release, which is expected to be August 2, 2023. ", "On that day, BorgWarner is projected to report earnings of $1.13 per share, which would represent year-over-year growth of 7.62%. "
- What's in the offing for borgwarner (bwa) in Q2 earnings?. According to Zacks on Wednesday, 26 July, "On the flip side, BorgWarner has been bearing the brunt of high SG&A costs over the past several quarters and the trend is likely to have clipped margins in the quarter under review. "
8. AECOM (ACM)
5.1% sales growth and 17.09% return on equity
AECOM, together with its subsidiaries, engages in designing, building, financing, and operating infrastructure assets worldwide. It operates through four segments: Design and Consulting Services (DCS), Construction Services (CS), Management Services (MS), and AECOM Capital (ACAP). The DCS segment offers planning, consulting, architectural and engineering design, program management, and construction management services for industrial, commercial, institutional, and government clients, including the transportation, facilities, environmental, energy, and water markets. The CS segment provides building construction and energy, as well as infrastructure and industrial construction services. The MS segment offers program and facilities management and maintenance, training, logistics, consulting, technical assistance, and systems integration and information technology services primarily for agencies of the United States government and other national governments. The ACAP segment invests in and develops real estate projects. The company was formerly known as AECOM Technology Corporation and changed its name to AECOM in January 2015. AECOM was founded in 1980 and is headquartered in Los Angeles, California.
Earnings Per Share
As for profitability, AECOM has a trailing twelve months EPS of $3.03.
PE Ratio
AECOM has a trailing twelve months price to earnings ratio of 28.5. Meaning, the purchaser of the share is investing $28.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.09%.
Volume
Today’s last reported volume for AECOM is 608783 which is 32.77% below its average volume of 905634.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 9.3% and 10.1%, respectively.
